Qixing Pilot Appears at the 2025 South China Hospital Information Network Conference: Empowering Smart Medical Care with Innovative Technology

On March 21, 2025, the 2025 South China Hospital Information Network Conference, themed "New Quality Healthcare, Smart Future," grandly opened at the Guangzhou Baiyun International Convention Center. This three-day industry event, focusing on innovation and high-quality development in healthcare information technology, attracted medical and health institutions, technology companies, and industry experts from across the country. Seven Star Navigator, a leader in smart healthcare solutions, showcased a variety of innovative products at the booth, capturing the spotlight with its immersive interactive experience and robust technical expertise.

As a terminal manufacturer qualified by the National Human Resources and Social Security Administration, Qixing Linghang's products have always served the medical industry. At the South China Hospital Information Network Conference, Qixing Linghang launched new products such as brand-new card readers and drug traceability scanners, demonstrating the company's ability to respond promptly to the latest demands and pain points of the pharmaceutical industry. It also witnessed the vigorous momentum of high-quality development of digital medical applications, attracted the attention and love of many experts, and attracted customers and visitors to rush to experience and stop to negotiate.

Among them, the core exhibit, the QX100-JAA3 drug identification terminal, has attracted industry attention. The company actively responded to the National Medical Insurance Administration's policy of "sweeping all possible drug traceability codes" and provided digital pharmaceutical solutions. The device uses three-party collaboration (drug supervision, medical insurance, and hospitals) to promote the full-process and full-volume collection of drug traceability codes in the fields of medical insurance and work-related injuries, realize the efficient integration and sharing of data elements, and provide strong guarantees for the safe circulation of drugs.

The device supports AI batch quick scanning, 60 frames per second high-frequency acquisition, intelligent voice broadcast, anti-duplication design, and anti-interference precise identification, with a 300% increase in efficiency, more convenient plug-and-play, and seamless integration with the HIS system. Its high efficiency, accuracy, and ease of operation greatly improve the efficiency of drug traceability code collection, reduce the workload of personnel collection, and avoid human omissions, making drug source information clear and traceable, and facilitating the efficient implementation of drug traceability code collection and tracing. It is widely used in hospital pharmacies, drug production, and pharmaceutical retail.

In the future, Qixing Linghang will continue to uphold the values ​​of "innovation, progress, and responsibility", continue research and development and innovation, deeply cultivate the needs of different scenarios in the medical industry, provide users with more high-quality products and digital application solutions and services, and contribute to the progress and development of medical digital applications.